Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

Inari Medical (NASDAQ:NARI – Free Report ... capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large ...

Inari Medical has a 12 month low of $36.73 and a ... capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral. Analyst Price Forecast Suggests 14.00% Downside As of December 23, 2024, ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

based Stryker has offered $4.9 billion to buy Inari Medical Inc., a California company that specializes in equipment for venous thromboembolism (VTE) systems to treat blood clots such as pulmonary ...